Matches in SemOpenAlex for { <https://semopenalex.org/work/W4381572251> ?p ?o ?g. }
Showing items 1 to 96 of
96
with 100 items per page.
- W4381572251 abstract "Tixagevimab/cilgavimab is a monoclonal antibody used to prevent coronavirus disease 2019 among immunocompromised hosts and maintained neutralizing activity against early omicron variants. Omicron BN.1 became a dominant circulating strain in Korea early 2023, but its susceptibility to tixagevimab/cilgavimab is unclear. We conducted plaque reduction neutralization test (PRNT) against BN.1 in a prospective cohort (14 patients and 30 specimens). BN.1 PRNT was conducted for one- and three-months after tixagevimab/cilgavimab administration and the average PRNT ND50 of each point was lower than the positive cut-off value of 20 (12.9 ± 4.5 and 13.2 ± 4.2, respectively, P = 0.825). In the paired analyses, tixagevimab/cilgavimab-administered sera could not actively neutralize BN.1 (PRNT ND50 11.5 ± 2.9, P = 0.001), compared with the reserved activity against BA.5 (ND50 310.5 ± 180.4). Unlike virus-like particle assay, tixagevimab/cilgavimab was not active against BN.1 in neutralizing assay, and would not be effective in the present predominance of BA.2.75 sublineages." @default.
- W4381572251 created "2023-06-22" @default.
- W4381572251 creator A5001531905 @default.
- W4381572251 creator A5001791857 @default.
- W4381572251 creator A5003498862 @default.
- W4381572251 creator A5007621594 @default.
- W4381572251 creator A5014510042 @default.
- W4381572251 creator A5014809816 @default.
- W4381572251 creator A5016707928 @default.
- W4381572251 creator A5022426720 @default.
- W4381572251 creator A5024979443 @default.
- W4381572251 creator A5032787683 @default.
- W4381572251 creator A5034069977 @default.
- W4381572251 creator A5036053743 @default.
- W4381572251 creator A5036477222 @default.
- W4381572251 creator A5046469412 @default.
- W4381572251 creator A5065460903 @default.
- W4381572251 creator A5070443355 @default.
- W4381572251 creator A5077494688 @default.
- W4381572251 creator A5082428721 @default.
- W4381572251 creator A5089245500 @default.
- W4381572251 date "2023-01-01" @default.
- W4381572251 modified "2023-09-26" @default.
- W4381572251 title "Loss of Neutralizing Activity of Tixagevimab/Cilgavimab (Evusheld™) Against Omicron BN.1, a Dominant Circulating Strain Following BA.5 During the Seventh Domestic Outbreak in Korea in Early 2023" @default.
- W4381572251 cites W2793350103 @default.
- W4381572251 cites W3215399721 @default.
- W4381572251 cites W4200087051 @default.
- W4381572251 cites W4206984346 @default.
- W4381572251 cites W4225661243 @default.
- W4381572251 cites W4226525051 @default.
- W4381572251 cites W4281665851 @default.
- W4381572251 cites W4307975583 @default.
- W4381572251 cites W4313431775 @default.
- W4381572251 cites W4313473554 @default.
- W4381572251 cites W4320728217 @default.
- W4381572251 cites W4322773298 @default.
- W4381572251 cites W4362569701 @default.
- W4381572251 doi "https://doi.org/10.3346/jkms.2023.38.e205" @default.
- W4381572251 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37431539" @default.
- W4381572251 hasPublicationYear "2023" @default.
- W4381572251 type Work @default.
- W4381572251 citedByCount "0" @default.
- W4381572251 crossrefType "journal-article" @default.
- W4381572251 hasAuthorship W4381572251A5001531905 @default.
- W4381572251 hasAuthorship W4381572251A5001791857 @default.
- W4381572251 hasAuthorship W4381572251A5003498862 @default.
- W4381572251 hasAuthorship W4381572251A5007621594 @default.
- W4381572251 hasAuthorship W4381572251A5014510042 @default.
- W4381572251 hasAuthorship W4381572251A5014809816 @default.
- W4381572251 hasAuthorship W4381572251A5016707928 @default.
- W4381572251 hasAuthorship W4381572251A5022426720 @default.
- W4381572251 hasAuthorship W4381572251A5024979443 @default.
- W4381572251 hasAuthorship W4381572251A5032787683 @default.
- W4381572251 hasAuthorship W4381572251A5034069977 @default.
- W4381572251 hasAuthorship W4381572251A5036053743 @default.
- W4381572251 hasAuthorship W4381572251A5036477222 @default.
- W4381572251 hasAuthorship W4381572251A5046469412 @default.
- W4381572251 hasAuthorship W4381572251A5065460903 @default.
- W4381572251 hasAuthorship W4381572251A5070443355 @default.
- W4381572251 hasAuthorship W4381572251A5077494688 @default.
- W4381572251 hasAuthorship W4381572251A5082428721 @default.
- W4381572251 hasAuthorship W4381572251A5089245500 @default.
- W4381572251 hasBestOaLocation W43815722511 @default.
- W4381572251 hasConcept C116675565 @default.
- W4381572251 hasConcept C138894074 @default.
- W4381572251 hasConcept C14086860 @default.
- W4381572251 hasConcept C159047783 @default.
- W4381572251 hasConcept C2522874641 @default.
- W4381572251 hasConcept C71924100 @default.
- W4381572251 hasConceptScore W4381572251C116675565 @default.
- W4381572251 hasConceptScore W4381572251C138894074 @default.
- W4381572251 hasConceptScore W4381572251C14086860 @default.
- W4381572251 hasConceptScore W4381572251C159047783 @default.
- W4381572251 hasConceptScore W4381572251C2522874641 @default.
- W4381572251 hasConceptScore W4381572251C71924100 @default.
- W4381572251 hasFunder F4320318372 @default.
- W4381572251 hasIssue "27" @default.
- W4381572251 hasLocation W43815722511 @default.
- W4381572251 hasLocation W43815722512 @default.
- W4381572251 hasLocation W43815722513 @default.
- W4381572251 hasOpenAccess W4381572251 @default.
- W4381572251 hasPrimaryLocation W43815722511 @default.
- W4381572251 hasRelatedWork W202657355 @default.
- W4381572251 hasRelatedWork W2058074887 @default.
- W4381572251 hasRelatedWork W2059556547 @default.
- W4381572251 hasRelatedWork W213396474 @default.
- W4381572251 hasRelatedWork W2435535700 @default.
- W4381572251 hasRelatedWork W2789553473 @default.
- W4381572251 hasRelatedWork W3034590614 @default.
- W4381572251 hasRelatedWork W37257015 @default.
- W4381572251 hasRelatedWork W4229459136 @default.
- W4381572251 hasRelatedWork W4290202528 @default.
- W4381572251 hasVolume "38" @default.
- W4381572251 isParatext "false" @default.
- W4381572251 isRetracted "false" @default.
- W4381572251 workType "article" @default.